Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples

Minfeng Xiao(BGI Group (China)), Jiandong Li(Inner Mongolia Electric Power (China)), Honglong Wu(Fujian Medical University), Jincun Zhao(ShanghaiTech University), Taiqing Feng(Shenzhen Metro (China)), Jielun Cai(BGI Group (China)), Guifang Yang(Central South University), Fang Chen(Shenyang Pharmaceutical University), Jingkai Ji(BGI Group (China)), Ziqing Deng(Tsinghua University), Daxi Wang(BGI Group (China)), Yanping Zhao(BGI Group (China)), Tianzhu Liang(Botswana Geoscience Institute), Weijun Chen(Hainan University), Junhua Li(BGI Group (China)), Yanyan Zhang(Shandong First Medical University), Xun Xu(Zhejiang Lab), Huanzi Zhong(BGI Group (China)), Lin Yang(Second Affiliated Hospital of Xi'an Jiaotong University), Peidi Ren(BGI Group (China)), Yanqun Wang(BGI Group (China)), Xiaoqing Liu(First Affiliated Hospital of Guangzhou Medical University), Min Li(Institut Pluridisciplinaire Hubert Curien), Tian Chen(Zhongda Hospital Southeast University), Zhihua Ou(BGI Group (China)), Jian Wang(Northern Jiangsu People's Hospital)
Genome Medicine
June 30, 2020
Cited by 158


Related Papers